NEW YORK ─ Inflammatix on Thursday announced it has been awarded $7.4 million by the US Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) to further develop a point-of-care test and system to diagnose infection by reading the immune system.
Menu
Home › Diagnostics › Molecular Diagnostics › Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test
Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test
Oct 29, 2020
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.
By MilliporeSigma
By MilliporeSigma
By MilliporeSigma
Mar
18
Featured Webinar
Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind
Sponsored by
Thermo Fisher Scientific
Mar
29
Featured Webinar
Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs
Sponsored by
Thermo Fisher Scientific
Mar
31
Sponsored by
MilliporeSigma
What's Popular?
In Molecular Diagnostics
Sponsorships
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.